Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2375]
News [3438]
Articles [281]
Editorials [30]
Conferences [171]
elearning [101]
ASCO 2019 and vision for cancer control
Dr Eduardo Cazap - Editor-in-Chief, ecancer
ASCO 2019 and vision for cancer control ( Dr Eduardo Cazap - Editor-in-Chief, ecancer )
11 Jun 2019
Metastatic castration resistant prostate cancer: Updates from ASCO 2019
Dr Neal Shore, Dr Joaquin Mateo and Prof Karim Fizazi
Metastatic castration resistant prostate cancer: Updates from ASCO 2019 ( Dr Neal Shore, Dr Joaquin Mateo and Prof Karim Fizazi )
7 Jun 2019
Preliminary results of earlier steroid use with axicabtagene ciloleucel in...
Prof Max Topp - University of Würzburg, Würzburg, Germany
Preliminary results of earlier steroid use with axicabtagene ciloleucel in patients with R/R large B cell lymphoma ( Prof Max Topp - University of Würzburg, Würzburg, Germany )
6 Jun 2019
Evaluation of AMG 420, an anti-BCMA bispecific T-cell engager (BiTE)...
Prof Max Topp - University of Würzburg, Würzburg, Germany
Evaluation of AMG 420, an anti-BCMA bispecific T-cell engager (BiTE) immunotherapy in patients with R/R multiple myeloma ( Prof Max Topp - University of Würzburg, Würzburg, Germany )
6 Jun 2019
POLO Trial: Olaparib as a maintenance treatment following first-line...
Dr Teresa Macarulla - Vall d’Hebron Barcelona University Hospital, Barcelona...
POLO Trial: Olaparib as a maintenance treatment following first-line chemotherapy in patients with metastatic pancreatic cancer ( Dr Teresa Macarulla - Vall d’Hebron Barcelona University Hospital, Barcelona, Spain )
6 Jun 2019
Weekly 20/56 mg/m² carfilzomib, lenalidomide and dexamethasone until...
Prof Xavier Leleu - Centre Hospitalier Universitaire de Lille, Lille, France
Weekly 20/56 mg/m² carfilzomib, lenalidomide and dexamethasone until progression in early relapsed refractory multiple myeloma ( Prof Xavier Leleu - Centre Hospitalier Universitaire de Lille, Lille, France )
6 Jun 2019
Maintenance with weekly carfilzomib in elderly newly diagnosed multiple myeloma
Prof Xavier Leleu - Centre Hospitalier Universitaire de Lille, Lille, France
Maintenance with weekly carfilzomib in elderly newly diagnosed multiple myeloma ( Prof Xavier Leleu - Centre Hospitalier Universitaire de Lille, Lille, France )
6 Jun 2019
ZUMA-3: A study of KTE-X19 in adults with relapsed/refractory acute...
Dr Bijal Shah - H. Lee Moffitt Cancer Center & Research Institute, Tampa, USA
ZUMA-3: A study of KTE-X19 in adults with relapsed/refractory acute lymphoblastic leukaemia ( Dr Bijal Shah - H. Lee Moffitt Cancer Center & Research Institute, Tampa, USA )
6 Jun 2019
Predictive models for treatment risk in cancer
Dr Charlotte Moser - Founder weCancerTALK
Predictive models for treatment risk in cancer ( Dr Charlotte Moser - Founder weCancerTALK )
5 Jun 2019
A severe lack of cancer care in Burundi
Dr Canesius Uwizeyimana - Radiation Oncology Medical Physicist, Bujumbura...
A severe lack of cancer care in Burundi ( Dr Canesius Uwizeyimana - Radiation Oncology Medical Physicist, Bujumbura, Burundi )
5 Jun 2019
Better education about breast cancer treatment in Africa
Dr Beatrice Wiafe-Addai - Peace And Love Hospital Breast care International...
Better education about breast cancer treatment in Africa ( Dr Beatrice Wiafe-Addai - Peace And Love Hospital Breast care International, Accra, Ghana )
5 Jun 2019
Improving radiotherapy access in Africa
Dow Wilson - CEO, Varian Medical Systems
Improving radiotherapy access in Africa ( Dow Wilson - CEO, Varian Medical Systems )
5 Jun 2019

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation